Table 1.
Treatment | Maximum contraction (% KCl) | |
---|---|---|
Control | 138±1.9 | |
17β-estradiol 1 nM | 119±1.4 | * |
Isoproterenol 1 nM | 124±2.7 | * |
17β-estradiol 1 nM+isoproterenol 1 nM | 123±2.9 | * |
Control | 145±3.6 | |
17β-estradiol 1 nM | 124±4.8 | * |
8-Br-cAMP 10 μM | 125±5.1 | * |
17β-estradiol 1 nM+8-Br-cAMP 10 μM | 123±4.8 | * |
Control | 141±4.0 | |
17β-estradiol 1 nM | 122±7.1 | * |
8-Br-cGMP 3 μM | 122±4.1 | * |
17β-estradiol 1 nM+8-Br-cGMP 3 μM | 126±5.1 |
Data represent mean±s.e.m. n=6–7 in each treatment group.
P<0.05 vs corresponding controls (ANOVA–Dunnett's).